BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 32395964)

  • 1. [Dealing with COVID-19-associated coagulopathy].
    Klok FA; den Exter PL; Huisman MV; Eikenboom J
    Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32395964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy of Coronavirus Disease 2019.
    Iba T; Levy JH; Levi M; Connors JM; Thachil J
    Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unique characteristics of COVID-19 coagulopathy.
    Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M
    Crit Care; 2020 Jun; 24(1):360. PubMed ID: 32552865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19].
    Mei H; Hu Y
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):185-191. PubMed ID: 32133825
    [No Abstract]   [Full Text] [Related]  

  • 5. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients.
    Ahmed SI; Khan S
    Curr Probl Cardiol; 2020 Sep; 45(9):100648. PubMed ID: 32703535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection.
    Llau JV; Ferrandis R; Sierra P; Hidalgo F; Cassinello C; Gómez-Luque A; Quintana M; Amezaga R; Gero M; Serrano A; Marcos P
    Rev Esp Anestesiol Reanim (Engl Ed); 2020; 67(7):391-399. PubMed ID: 32591185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.
    Godoy LC; Goligher EC; Lawler PR; Slutsky AS; Zarychanski R
    CMAJ; 2020 Oct; 192(40):E1156-E1161. PubMed ID: 32816822
    [No Abstract]   [Full Text] [Related]  

  • 8. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19.
    Song JC; Wang G; Zhang W; Zhang Y; Li WQ; Zhou Z;
    Mil Med Res; 2020 Apr; 7(1):19. PubMed ID: 32307014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-associated coagulopathy: An exploration of mechanisms.
    Colling ME; Kanthi Y
    Vasc Med; 2020 Oct; 25(5):471-478. PubMed ID: 32558620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: Complement, Coagulation, and Collateral Damage.
    Lo MW; Kemper C; Woodruff TM
    J Immunol; 2020 Sep; 205(6):1488-1495. PubMed ID: 32699160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms.
    Tersalvi G; Vicenzi M; Calabretta D; Biasco L; Pedrazzini G; Winterton D
    J Card Fail; 2020 Jun; 26(6):470-475. PubMed ID: 32315733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and Hypercoagulability: A Review.
    Kichloo A; Dettloff K; Aljadah M; Albosta M; Jamal S; Singh J; Wani F; Kumar A; Vallabhaneni S; Khan MZ
    Clin Appl Thromb Hemost; 2020; 26():1076029620962853. PubMed ID: 33074732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19.
    Droesch C; Do MH; DeSancho M; Lee EJ; Magro C; Harp J
    JAMA Dermatol; 2020 Sep; 156(9):1-3. PubMed ID: 32756881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cells orchestrate COVID-19 coagulopathy.
    O'Sullivan JM; Gonagle DM; Ward SE; Preston RJS; O'Donnell JS
    Lancet Haematol; 2020 Aug; 7(8):e553-e555. PubMed ID: 32619412
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in the relationship between coronavirus infection and coagulation function.
    Zou H; Xiong WF
    Chin Med J (Engl); 2020 Jun; 133(12):1489-1490. PubMed ID: 32209889
    [No Abstract]   [Full Text] [Related]  

  • 16. The Janus Face of Coronavirus Disease 2019-Associated Coagulopathy.
    Stahl K; Seeliger B; Hofmaenner DA; Doebler M; Bode C; David S
    Crit Care Med; 2021 Oct; 49(10):e1049-e1050. PubMed ID: 34048369
    [No Abstract]   [Full Text] [Related]  

  • 17. Special Issue "COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies".
    Russu E; Arbănaşi EM; Șchiopu A
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the Editor in Response to "Coagulation Abnormalities and Clinical Complications in Children With SARS-CoV-2: A Systematic Review of 48,322 Patients" Published in December 2021.
    Dain AS; Whitworth H; Raffini L
    J Pediatr Hematol Oncol; 2023 Jan; 45(1):44-45. PubMed ID: 35973085
    [No Abstract]   [Full Text] [Related]  

  • 19. Coagulopathy and cannabinoids: what the radiologist should know.
    O'Shea A
    Eur Radiol; 2024 Jul; 34(7):4538-4539. PubMed ID: 38133676
    [No Abstract]   [Full Text] [Related]  

  • 20. Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
    Mohamed-Hussein AAR; Aly KME; Ibrahim MAA
    Med Hypotheses; 2020 Nov; 144():109975. PubMed ID: 32531536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.